Editorial: Protein kinase inhibitors in neurodegeneration and cancer targeted therapies

Front Cell Dev Biol. 2024 Apr 18:12:1413293. doi: 10.3389/fcell.2024.1413293. eCollection 2024.
No abstract available

Keywords: cancer; cancer therapies; mutation; neurodegenenerative diseases; protein kinase.

Publication types

  • Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.